Private foundation
COLLINS MEDICAL TRUST
MINNEAPOLIS, MNEIN
Can I apply?
The funder's latest Form 990-PF says it accepts applications. Read the instructions below before you write.
- How to apply
- Deadlines
Private foundation
MINNEAPOLIS, MNEIN
The funder's latest Form 990-PF says it accepts applications. Read the instructions below before you write.
Application policy: Accepts applications, as stated on the FY2025 return.
These lines count this foundation's own Form 990-PF returns that the IRS has published as data. An amended return replaces its original. They describe past returns only.
This is a count from past returns. It does not say the foundation will consider a new request. How it is counted: names are compared as written on the returns, without "The" at the start, without endings such as "Inc" or "LLC", and without spaces and punctuation. A recipient also counts as already listed when our records link it to the same organization as an earlier recipient, or when its name is almost the same as an earlier name (a trigram similarity of 0.8 or more, where 1 means identical). The state on the grant row is not compared. Grants that the foundation marked as paid to an individual, such as a scholarship, are left out of both numbers, and no count is shown when most of its grants are marked that way. A person whom the foundation did not mark as an individual is still counted as a recipient. A recipient can still look new when its name is written very differently from year to year, and two different recipients with almost the same name can be counted as one.
Application guidance comes from the funder's own Form 990-PF, Part XV (the section where a private foundation says how to apply), shown as filed. It is the funder's words, not ours. These fields are free text and the IRS form cuts them short. Filers sometimes put whole sentences in the contact-name box. Shown exactly as filed.
Giving by year
Total assets by year
| Year | Form | Revenue | Expenses | Giving | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2025 | 990-PF | $573,234 | $598,619 | $583,451 | $14,760,453 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
Recipient focus areas
Where recipients are
Based on the 3% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| PROVIDENCE PORTLAND MEDICAL FDNPortland, OR | A Tetrahedral DNA Nanostructure-Based Nanocomplex for Post-Surgical Cancer Immunotherapy, Di Wen, PhD | $30,000 | 2023 | |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Truman Collins Jr | TRUSTEE | 1.00 | $0 |
| Virginia Tilden | TRUSTEE | 1.00 | $2,000 |
| Ryan Luria | TRUSTEE | 1.00 | $0 |
| Tamara Potruch | ADMINISTRATOR |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| $14,628,959 |
| FY2024 | 990-PF | $414,132 | $592,315 | $585,547 | $12,992,665 | $12,890,097 |
| FY2023 | 990-PF | $843,068 | $680,095 | $665,944 | $10,957,538 | $10,891,116 |
| FY2022 | 990-PF | $1,521,870 | $503,165 | $481,585 | $10,569,529 | $10,495,846 |
| FY2021 | 990-PF | $857,977 | $514,594 | $502,207 | $11,287,726 | $11,189,045 |
| FY2020 | 990-PF | $1,049,815 | $507,698 | $496,768 | $8,321,355 | $8,262,238 |
| FY2019 | 990-PF | $425,910 | $522,010 | $517,289 | $8,737,370 | $8,686,365 |
| FY2018 | 990-PF | $633,569 | $560,293 | $553,573 | $9,604,926 | $9,543,907 |
| FY2017 | 990-PF | $324,836 | $522,331 | $517,220 | $9,760,156 | $9,703,121 |
| FY2016 | 990-PF | $887,620 | $475,573 | $466,367 | $8,541,451 | $8,488,724 |
| OHSU FoundationPortland, OR |
| Studying peripheral nerve synucleinopathy in autonomic nerve subtypes in prodromal Parkinson's Disease, Gregory Scott, MD, PhD |
| $30,000 |
| 2022 |
| OHSU FoundationPortland, OR | Molecular signature of a tumor-promoting cancer stem cell niche -Naoki Oshimori, PhD | $30,000 | 2019 |
| OHSU FoundationPortland, OR | Cell Specific Delivery of Harmine Using Antibody Directed Nanocarriers for the Targeted Treatment of Type-1-Diabetes (T1D) Swati Mishra, Ph.D. | $30,000 | 2017 |
| PROVIDENCE ST VINCENT MED FDTNPortland, OR | Providence St. Vincent Nursing Scholarship Program | $30,000 | 2023 |
| OHSU FoundationPortland, OR | Type I/III interferons in mucosal immunity to enteric viral infection, Timothy Nice, PhD | $30,000 | 2016 |
| OHSU FoundationPortland, OR | Correcting inheritable BRCA mutations in the human germlineNuria Marti Gutierrez, PhD | $30,000 | 2019 |
| OHSU FoundationPortland, OR | OHSU and OSU Partnering in Portland for Rare Diseases - Penelope Hogarth, M.D. | $30,000 | 2017 |
| OHSU FoundationPortland, OR | Computational analysis of dynamic alternative polyadenylation usages in immune system - Zheng Xia, PhD | $30,000 | 2018 |
| OHSU FoundationPORTLAND, OR | Characterization of innate immune cells in the cochlea following noise damage, Aude Chiot, PhD | $30,000 | 2023 |
| PORTLAND VA RESEARCH FOUNDATIONPORTLAND, OR | Contribution of the inflammasome to radiation response in pancreatic cancer - Terry R. Medler, PhD | $30,000 | 2019 |
| OREGON STATE UNIVERSITYCORVALLIS, OR | Evolving long-lived yeast: developing model populations with postponed aging to identify candidate genes for improving human healthspan, - Molly K Burke, PhD | $30,000 | 2019 |
| OHSU FoundationPortland, OR | A Novel Approach to Reveal Immune Cell Biomarkers in Patients with Metastatic Prostate Cancer - Amy Moran, PhD | $30,000 | 2018 |
| OHSU FoundationPortland, OR | Evaluation of M?cancer Cell Hybrids in Circulation During Treatment of Patients with Colorectal Cancer - Luai Zarour, MD | $30,000 | 2017 |
| Linfield College-School of NursingMcMinnville, OR | PAQUET Nursing Scholarships | $30,000 | 2022 |
| OHSU FoundationPortland, OR | Neoplastic Immune Surface Mimicry as a Modulator of the Immune ResponseAgainst Breast Cancer, Eric Berens, PhD | $30,000 | 2022 |
| OHSU FOUNDATIONPORTLAND, OR | VOLUMETRIC BIOMARKERS TO PREDICT RETINOPATHY OF PREMATURITY PROGRESSION | $30,000 | 2024 |
| OHSU FOUNDATIONPORTLAND, OR | INVESTIGATING THE MODE OF ACTION OF CET-6D, A FIRST-IN-CLASS PIM-1 PROTEIN DEGRADER | $30,000 | 2024 |
| OHSU FoundationPortland, OR | Role of Neurogenesis on Cognitive Recovery After Brain Injury - Laura Villasana, Ph.D | $30,000 | 2017 |
| OHSU FOUNDATIONPORTLAND, OR | DISSECTING THE NEURAL STEM CELL STATE DURING ZEBRAFISH SPINAL CORD REGENERATION | $30,000 | 2024 |
| OHSU FoundationPortland, OR | Circulating Hybrid Cells as a Biomarker of Response to Neo-adjuvant Chemotherapy in Pancreatic Cancer, Ranish Patel, MD | $30,000 | 2023 |
| OHSU FoundationPortland, OR | MS-related Fatigue: Central Mechanisms and Implication for Balance Control, Ishu Arpan, PhD | $30,000 | 2016 |
| OHSU FoundationPortland, OR | Defining the Role of Mesangial Cell Angiotensin Signaling in Diabetic Kidney Disease, - Jonathan Nelson, PhD | $30,000 | 2019 |
| LEWIS CLARK COLLEGEPORTLAND, OR | A new in vivo model to study alpha-synuclein aggregation in Parkinsons DiseaseTamily Weissman, PhD | $30,000 | 2021 |
| PROVIDENCE PORTLAND MEDICAL FOUNDATIONPORTLAND, OR | STUDYING T CELL EXHAUSTION TO IMPROVE CANCER TREATMENT WITH THE GENERATION OF NOVEL MOUSE MODEL | $30,000 | 2024 |
| 1.00 |
| $0 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990-PF · FY2024 · period ending Sep 30, 2024IRS bulk XML
Filing id 202510419349100106
Form 990-PF · FY2023 · period ending Sep 30, 2023
Filing id 202332929349100908
Form 990-PF · FY2022 · period ending Sep 30, 2022
Filing id 202310349349100701
Form 990-PF · FY2021 · period ending Sep 30, 2021
Filing id 202221589349101702
Form 990-PF · FY2020 · period ending Sep 30, 2020
Filing id 202110359349100411
Form 990-PF · FY2019 · period ending Sep 30, 2019
Filing id 202040389349101019
Form 990-PF · FY2018 · period ending Sep 30, 2018
Filing id 201920369349100602
Form 990-PF · FY2017 · period ending Sep 30, 2017
Filing id 201820339349100202
Form 990-PF · FY2016 · period ending Sep 30, 2016
Filing id 201710449349100226
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.